Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

Related Articles by Review for PubMed (Select 17017974)

1.

Targeting tumor-related immunosuppression for cancer immunotherapy.

Frumento G, Piazza T, Di Carlo E, Ferrini S.

Endocr Metab Immune Disord Drug Targets. 2006 Sep;6(3):233-7. Review.

PMID:
17017974
2.

Regulation of regulatory T cells: role of dendritic cells and toll-like receptors.

Kabelitz D, Wesch D, Oberg HH.

Crit Rev Immunol. 2006;26(4):291-306. Review.

PMID:
17073555
3.

The characterization and role of regulatory T cells in immune reactions.

Wilczynski JR, Radwan M, Kalinka J.

Front Biosci. 2008 Jan 1;13:2266-74. Review.

PMID:
17981708
4.

Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.

Khawli LA, Hu P, Epstein AL.

Handb Exp Pharmacol. 2008;(181):291-328. Review.

PMID:
18071951
5.

Regulatory T cells in tumor immunity.

Nishikawa H, Sakaguchi S.

Int J Cancer. 2010 Aug 15;127(4):759-67. doi: 10.1002/ijc.25429. Review.

PMID:
20518016
6.

Therapeutic gene modified cell based cancer vaccines.

Kozłowska A, Mackiewicz J, Mackiewicz A.

Gene. 2013 Aug 10;525(2):200-7. doi: 10.1016/j.gene.2013.03.056. Epub 2013 Apr 6. Review.

PMID:
23566846
7.

Thymic regulatory T cells.

Maggi E, Cosmi L, Liotta F, Romagnani P, Romagnani S, Annunziato F.

Autoimmun Rev. 2005 Nov;4(8):579-86. Review.

PMID:
16214099
8.

CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer.

Wang RF.

Hum Immunol. 2008 Nov;69(11):811-4. doi: 10.1016/j.humimm.2008.08.276. Epub 2008 Sep 24. Review.

PMID:
18817828
9.

Peripheral generation and function of CD4+CD25+ regulatory T cells.

Taams LS, Akbar AN.

Curr Top Microbiol Immunol. 2005;293:115-31. Review.

PMID:
15981478
10.

Human CD(4+)CD(25+) regulatory T cells and infectious tolerance.

Stassen M, Schmitt E, Jonuleit H.

Transplantation. 2004 Jan 15;77(1 Suppl):S23-5. Review.

PMID:
14726765
11.

The role of regulatory T lymphocytes in the induced immune response mediated by biological vaccines.

López M, Aguilera R, Pérez C, Mendoza-Naranjo A, Pereda C, Ramirez M, Ferrada C, Aguillón JC, Salazar-Onfray F.

Immunobiology. 2006;211(1-2):127-36. Epub 2006 Jan 4. Review.

PMID:
16446177
12.

Regulatory T cells and innate immune regulation in tumor immunity.

Wang RF.

Springer Semin Immunopathol. 2006 Aug;28(1):17-23. Epub 2006 Jul 13. Review. Erratum in: Springer Semin Immunopathol. 2006 Aug;28(1):77.

PMID:
16838179
13.

Cooperation of liver cells in health and disease.

Kmieć Z.

Adv Anat Embryol Cell Biol. 2001;161:III-XIII, 1-151. Review.

PMID:
11729749
14.

Targeting regulatory T cells.

Ménétrier-Caux C, Curiel T, Faget J, Manuel M, Caux C, Zou W.

Target Oncol. 2012 Mar;7(1):15-28. doi: 10.1007/s11523-012-0208-y. Epub 2012 Feb 12. Review.

PMID:
22327882
15.

Regulatory T cells in immune surveillance and treatment of cancer.

Yamaguchi T, Sakaguchi S.

Semin Cancer Biol. 2006 Apr;16(2):115-23. Epub 2006 Jan 11. Review.

PMID:
16376102
16.

Expanding and converting regulatory T cells: a horizon for immunotherapy.

Khattar M, Chen W, Stepkowski SM.

Arch Immunol Ther Exp (Warsz). 2009 May-Jun;57(3):199-204. doi: 10.1007/s00005-009-0021-1. Epub 2009 May 29. Review.

PMID:
19479206
17.

Regulatory T cells and cancer.

Wang HY, Wang RF.

Curr Opin Immunol. 2007 Apr;19(2):217-23. Epub 2007 Feb 15. Review.

PMID:
17306521
18.

The significance of Treg cells in defective tumor immunity.

Kosmaczewska A, Ciszak L, Potoczek S, Frydecka I.

Arch Immunol Ther Exp (Warsz). 2008 May-Jun;56(3):181-91. doi: 10.1007/s00005-008-0018-1. Epub 2008 May 30. Review.

PMID:
18512029
19.

CD25+ CD4+ regulatory T-cells in cancer.

Linehan DC, Goedegebuure PS.

Immunol Res. 2005;32(1-3):155-68. Review.

PMID:
16106066
20.

Targeting CD4+CD25+FoxP3+ regulatory T-cells for the augmentation of cancer immunotherapy.

Schabowsky RH, Madireddi S, Sharma R, Yolcu ES, Shirwan H.

Curr Opin Investig Drugs. 2007 Dec;8(12):1002-8. Review.

PMID:
18058571
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk